Andrew Lerner
Director, Corporate Affairs and Investor Relations at Aktis Oncology
- Role
- Director, Corporate Affairs and Investor Relations at Aktis Oncology
- Location
- Chapel Hill, NC, US
- LinkedIn followers
- 500 followers
About Andrew Lerner
Biopharma professional with experience in strategic partnerships, therapeutic drug development, biotechnology transactions, and intellectual property strategy. Possess diverse expertise, including:• Board- and Executive-level Communication • Strategic Planning & Portfolio Management• Competitive Intelligence • Search & Evaluation• Intellectual Property Management• Partnerships & Transactions • Alliance Management
Experience
Director, Corporate Affairs and Investor Relations
Feb 2026 — Present
Education
University of California, Berkeley
BS, Chemistry
UNC School of Medicine
Doctor of Philosophy - PhD, Biochemistry and Biophysics
Defense Language Institute Foreign Language Center
AA, Russian
Skills
- Biophysics
- Antibodies
- Chromatin Immunoprecipitation
- Cell Culture
- Gel Electrophoresis
- Market Research
- Chromatography
- Public Speaking
- Cell Biology
- Research
- Veterans
- Electrophoresis
- Transfection
- Protein Engineering
- Project Management
- Western Blotting
- Confocal Microscopy
- Lifesciences
- Purification
- Protein Chemistry
- Hplc
- Molecular Biology
- Fluorescence Microscopy
- Pcr
- Real-Time Polymerase Chain Reaction (Qpcr)
- Biochemistry
- Biotechnology
- Protein Purification
- Mammalian Cell Culture
- Data Analysis
- Chemistry
- Experimental Design
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.